The Valens Company is a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products. The Company is focused on being the partner of choice for leading Canadian and international cannabis brands by providing best-in-class, proprietary services including CO2, ethanol, hydrocarbon, solvent-less and terpene extraction, analytical testing, formulation and white-label product development and manufacturing.
Valens is the largest third-party extraction company in Canada with an annual capacity of 425,000 kg of dried cannabis and hemp biomass at our purpose-built facility in Kelowna, British Columbia which is in the process of becoming European Union (EU) Good Manufacturing Practices (GMP) compliant. The Valens Company currently offers a wide range of product formats, including tinctures, two-piece caps, soft gels, oral sprays and vape pens as well as beverages, concentrates, topicals, edibles, injectables, natural health products and has a strong pipeline of next-generation products in development for future release.
Finally, the Company’s wholly-owned subsidiary Valens Labs is a Health Canada licensed ISO 17025 accredited cannabis testing lab providing sector-leading analytical services and has partnered with Thermo Fisher Scientific to develop a Centre of Excellence in Plant-Based Science. The Company expects to formally change its name in due course. For more information, please visit The Valens Company website. The Company’s investor deck can be found specifically at The Valens Company’s investor deck.
Read more about The Valens Company
Everett Knight | Executive Vice President, Corporate Development & Capital Markets@The Valens Company
Mr. Knight is Executive Vice President of Strategy & Investments where he oversees corporate strategy including mergers & acquisitions, marketing, & investor relations. Mr. Knight is known across the cannabis space for his expertise and thought leadership where he has been involved with working, analyzing, lobbying, investing, advising, & consulting throughout the cannabis value chain. Previous to Valens, Mr. Knight was a portfolio manager at Matco Financial Inc where he ran the Small Cap Fund and launched the first long only institutional Cannabis Fund in Canada and led them both become the top performing funds in their corresponding categories. He has toured over 85 facilities worldwide and analyzed over 1200+ cannabis globally where he accumulated a thorough understanding of the industry, regulations, subsectors, and the companies involved in this fast-growing space. His focus in the cannabis industry has shifted in recent years to developing a specialty in extraction, testing, formulation, & value-added products. Mr. Knight has spoken at 150+ cannabis events across the globe including trade shows, corporate conferences, investor events, government forums, and legal/regulatory debates.
“We are in the second inning of the development of one of the largest industries in the world and the hard work we put in today will lay the framework around the world” said Everett Knight, Executive Vice President, Strategy & Investments. “It’s personal to me. I’ve seen the benefits of cannabis first hand and I have a responsibility to pass on the knowledge I have accumulated so that others can have access to cannabis around the globe.”